28004480|t|A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in Apc(Min/+) mice
28004480|a|To investigate the in vivo effects of Lactobacillus rhamnosus GG (LGG) on intestinal polyp development and the interaction between this single - organism probiotic and the gut microbiota therein. The Apc(Min/+) mouse model was used to study the potential preventive effect of LGG on intestinal polyposis, while shotgun metagenomic sequencing was employed to characterize both taxonomic and functional changes within the gut microbial community. We found that the progression of intestinal polyps in the control group altered the community functional profile remarkably despite small variation in the taxonomic diversity. In comparison, the consumption of LGG helped maintain the overall functional potential and taxonomic profile in the resident microbes, thereby leading to a 25% decrease of total polyp counts. Furthermore, we found that LGG enriched those microbes or microbial activities related to short-chain fatty acid production (e.g. Roseburia and Coprococcus), as well as suppressed the ones that can lead to inflammation (e.g. Bilophila wadsworthia). Our study using shotgun metagenomics highlights how single probiotic LGG may exert its beneficial effects and decrease polyp formation in mice by maintaining gut microbial functionality. This probiotic intervention targeting microbiota may be used in conjugation with other dietary supplements or drugs as part of prevention strategies for early-stage colon cancer, after further clinical validations in human.
28004480	27	37	preventive	T080	C1456501
28004480	38	44	effect	T080	C1280500
28004480	48	74	Lactobacillus rhamnosus GG	T007	C1629836
28004480	78	94	intestinal polyp	T190	C0021846
28004480	95	104	formation	T169	C1522492
28004480	108	118	Apc(Min/+)	T028	C0162832
28004480	119	123	mice	T015	C0025929
28004480	127	138	investigate	T169	C1292732
28004480	143	150	in vivo	T082	C1515655
28004480	151	161	effects of	T080	C1704420
28004480	162	188	Lactobacillus rhamnosus GG	T007	C1629836
28004480	190	193	LGG	T007	C1629836
28004480	198	214	intestinal polyp	T190	C0021846
28004480	215	226	development	T169	C1527148
28004480	235	246	interaction	T169	C1704675
28004480	260	266	single	T081	C0205171
28004480	269	277	organism	T001	C0029235
28004480	278	287	probiotic	T007	C0525033
28004480	296	310	gut microbiota	T001	C4018878
28004480	324	334	Apc(Min/+)	T028	C0162832
28004480	335	340	mouse	T015	C0025929
28004480	341	346	model	T008	C0599779
28004480	369	378	potential	T080	C3245505
28004480	379	389	preventive	T080	C1456501
28004480	390	396	effect	T080	C1280500
28004480	400	403	LGG	T007	C1629836
28004480	407	427	intestinal polyposis	T047	C1257915
28004480	435	465	shotgun metagenomic sequencing	T063	C1519305
28004480	500	509	taxonomic	T169	C0008903
28004480	514	524	functional	T169	C0205245
28004480	525	532	changes	T169	C0392747
28004480	544	567	gut microbial community	T001	C4018878
28004480	587	598	progression	T169	C0449258
28004480	602	619	intestinal polyps	T190	C0021846
28004480	627	640	control group	T096	C0009932
28004480	641	648	altered	T169	C0392747
28004480	653	662	community	T070	C1253910
28004480	663	681	functional profile	T169	C0205245
28004480	724	733	taxonomic	T169	C0008903
28004480	734	743	diversity	T080	C1880371
28004480	748	758	comparison	T052	C1707455
28004480	764	775	consumption	T039	C1947907
28004480	779	782	LGG	T007	C1629836
28004480	811	821	functional	T169	C0205245
28004480	822	831	potential	T080	C3245505
28004480	836	853	taxonomic profile	T169	C0008903
28004480	861	878	resident microbes	T001	C4018878
28004480	905	913	decrease	T081	C0547047
28004480	917	922	total	T080	C0439810
28004480	923	928	polyp	T190	C0032584
28004480	929	935	counts	T081	C0439157
28004480	964	967	LGG	T007	C1629836
28004480	968	976	enriched	T168	C0359583
28004480	983	991	microbes	T001	C0445623
28004480	995	1004	microbial	T001	C0599840
28004480	1005	1015	activities	T052	C0441655
28004480	1027	1060	short-chain fatty acid production	T044	C1655805
28004480	1067	1076	Roseburia	T007	C0995401
28004480	1081	1092	Coprococcus	T007	C1004293
28004480	1106	1116	suppressed	T169	C1260953
28004480	1143	1155	inflammation	T046	C0021368
28004480	1162	1183	Bilophila wadsworthia	T007	C1005848
28004480	1202	1222	shotgun metagenomics	T063	C1519305
28004480	1238	1244	single	T081	C0205171
28004480	1245	1254	probiotic	T007	C0525033
28004480	1255	1258	LGG	T007	C1629836
28004480	1296	1304	decrease	T081	C0547047
28004480	1305	1310	polyp	T190	C0032584
28004480	1311	1320	formation	T169	C1522492
28004480	1324	1328	mice	T015	C0025929
28004480	1344	1357	gut microbial	T001	C4018878
28004480	1358	1371	functionality	T169	C0205245
28004480	1378	1387	probiotic	T007	C0525033
28004480	1388	1400	intervention	T061	C0184661
28004480	1401	1410	targeting	T169	C1521840
28004480	1411	1421	microbiota	T001	C2985398
28004480	1460	1479	dietary supplements	T168	C0242295
28004480	1483	1488	drugs	T121	C0013227
28004480	1500	1521	prevention strategies	T080	C2700409
28004480	1526	1537	early-stage	T079	C2363430
28004480	1538	1550	colon cancer	T191	C0009375
28004480	1566	1574	clinical	T080	C0205210
28004480	1575	1586	validations	T062	C1519941
28004480	1590	1595	human	T016	C0086418